GB1090754A - Improvements relating to immunising materials - Google Patents
Improvements relating to immunising materialsInfo
- Publication number
- GB1090754A GB1090754A GB30615/63A GB3061563A GB1090754A GB 1090754 A GB1090754 A GB 1090754A GB 30615/63 A GB30615/63 A GB 30615/63A GB 3061563 A GB3061563 A GB 3061563A GB 1090754 A GB1090754 A GB 1090754A
- Authority
- GB
- United Kingdom
- Prior art keywords
- strain
- horses
- mice
- escherichia coli
- vaccine
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired
Links
- 239000000463 material Substances 0.000 title abstract 5
- WSFSSNUMVMOOMR-UHFFFAOYSA-N Formaldehyde Chemical compound O=C WSFSSNUMVMOOMR-UHFFFAOYSA-N 0.000 abstract 12
- 241000699670 Mus sp. Species 0.000 abstract 6
- 241000588724 Escherichia coli Species 0.000 abstract 4
- 241001465754 Metazoa Species 0.000 abstract 4
- 238000000034 method Methods 0.000 abstract 4
- 230000001681 protective effect Effects 0.000 abstract 4
- 239000000725 suspension Substances 0.000 abstract 4
- 229960005486 vaccine Drugs 0.000 abstract 4
- 206010061126 Escherichia infection Diseases 0.000 abstract 2
- 241000699666 Mus <mouse, genus> Species 0.000 abstract 2
- FAPWRFPIFSIZLT-UHFFFAOYSA-M Sodium chloride Chemical compound [Na+].[Cl-] FAPWRFPIFSIZLT-UHFFFAOYSA-M 0.000 abstract 2
- 230000002238 attenuated effect Effects 0.000 abstract 2
- 239000006161 blood agar Substances 0.000 abstract 2
- 244000309466 calf Species 0.000 abstract 2
- 208000020612 escherichia coli infection Diseases 0.000 abstract 2
- 230000002779 inactivation Effects 0.000 abstract 2
- 239000007928 intraperitoneal injection Substances 0.000 abstract 2
- 239000002609 medium Substances 0.000 abstract 2
- 239000006916 nutrient agar Substances 0.000 abstract 2
- 230000002265 prevention Effects 0.000 abstract 2
- 210000002966 serum Anatomy 0.000 abstract 2
- 239000011780 sodium chloride Substances 0.000 abstract 2
- RTKIYNMVFMVABJ-UHFFFAOYSA-L thimerosal Chemical compound [Na+].CC[Hg]SC1=CC=CC=C1C([O-])=O RTKIYNMVFMVABJ-UHFFFAOYSA-L 0.000 abstract 2
- 229960004906 thiomersal Drugs 0.000 abstract 2
- 238000005406 washing Methods 0.000 abstract 2
- 229920001817 Agar Polymers 0.000 abstract 1
- 239000008272 agar Substances 0.000 abstract 1
- 235000015097 nutrients Nutrition 0.000 abstract 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
- C07K16/12—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from bacteria
- C07K16/1203—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from bacteria from Gram-negative bacteria
- C07K16/1228—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from bacteria from Gram-negative bacteria from Enterobacteriaceae (F), e.g. Citrobacter, Serratia, Proteus, Providencia, Morganella, Yersinia
- C07K16/1232—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from bacteria from Gram-negative bacteria from Enterobacteriaceae (F), e.g. Citrobacter, Serratia, Proteus, Providencia, Morganella, Yersinia from Escherichia (G)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K39/02—Bacterial antigens
- A61K39/025—Enterobacteriales, e.g. Enterobacter
- A61K39/0258—Escherichia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
-
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
- Y02A—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
- Y02A50/00—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
- Y02A50/30—Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Medicinal Chemistry (AREA)
- Immunology (AREA)
- Organic Chemistry (AREA)
- General Health & Medical Sciences (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Pharmacology & Pharmacy (AREA)
- Molecular Biology (AREA)
- Biophysics (AREA)
- Biochemistry (AREA)
- Microbiology (AREA)
- Mycology (AREA)
- Genetics & Genomics (AREA)
- Epidemiology (AREA)
- Animal Behavior & Ethology (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Micro-Organisms Or Cultivation Processes Thereof (AREA)
- Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
Priority Applications (12)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| BE651300D BE651300A (enrdf_load_stackoverflow) | 1963-08-01 | ||
| GB30615/63A GB1090754A (en) | 1963-08-01 | 1963-08-01 | Improvements relating to immunising materials |
| IL21785A IL21785A (en) | 1963-08-01 | 1964-07-28 | Immunising materials derived from a new strain of escherichia coli |
| CH1006664A CH484276A (de) | 1963-08-01 | 1964-07-31 | Verfahren zur Gewinnung eines Materials, welches zur Herstellung eines Impfstoffes zur Verhütung oder Behandlung von Escherichia-coli-Infektionen geeignet ist |
| FR1561053D FR1561053A (enrdf_load_stackoverflow) | 1963-08-01 | 1964-07-31 | |
| NL6408788A NL6408788A (enrdf_load_stackoverflow) | 1963-08-01 | 1964-07-31 | |
| ES0302685A ES302685A1 (es) | 1963-08-01 | 1964-07-31 | Un metodo para cultivar una cepa de escherichia coli. |
| DK380064AA DK113945B (da) | 1963-08-01 | 1964-07-31 | Fremgangsmåde til fremstilling af et middel til forebyggelse eller behandling af Escherichia coli-infektioner. |
| LU46667D LU46667A1 (enrdf_load_stackoverflow) | 1963-08-01 | 1964-07-31 | |
| AT659164A AT259133B (de) | 1963-08-01 | 1964-07-31 | Verfahren zur Herstellung von aktiv oder passiv immunisierendem Material gegen Escherichia coli-Infektionen |
| BR161321/64A BR6461321D0 (pt) | 1963-08-01 | 1964-07-31 | Aperfeicoamento em processo para a producao de uma vacina para a prevencao ou tratamento de infeccoes por escherichia coli |
| SE09377/64A SE328371B (enrdf_load_stackoverflow) | 1963-08-01 | 1964-08-03 |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| GB30615/63A GB1090754A (en) | 1963-08-01 | 1963-08-01 | Improvements relating to immunising materials |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| GB1090754A true GB1090754A (en) | 1967-11-15 |
Family
ID=10310436
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| GB30615/63A Expired GB1090754A (en) | 1963-08-01 | 1963-08-01 | Improvements relating to immunising materials |
Country Status (12)
Families Citing this family (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| IL59663A (en) * | 1980-03-19 | 1983-02-23 | Univ Ramot | Vaccines obtained from bacterial mutant strains of enterobacteriaceae and pseudomonaceae |
-
0
- BE BE651300D patent/BE651300A/xx unknown
-
1963
- 1963-08-01 GB GB30615/63A patent/GB1090754A/en not_active Expired
-
1964
- 1964-07-28 IL IL21785A patent/IL21785A/xx unknown
- 1964-07-31 CH CH1006664A patent/CH484276A/de unknown
- 1964-07-31 LU LU46667D patent/LU46667A1/xx unknown
- 1964-07-31 NL NL6408788A patent/NL6408788A/xx unknown
- 1964-07-31 BR BR161321/64A patent/BR6461321D0/pt unknown
- 1964-07-31 ES ES0302685A patent/ES302685A1/es not_active Expired
- 1964-07-31 AT AT659164A patent/AT259133B/de active
- 1964-07-31 DK DK380064AA patent/DK113945B/da unknown
- 1964-07-31 FR FR1561053D patent/FR1561053A/fr not_active Expired
- 1964-08-03 SE SE09377/64A patent/SE328371B/xx unknown
Also Published As
| Publication number | Publication date |
|---|---|
| FR1561053A (enrdf_load_stackoverflow) | 1969-03-28 |
| ES302685A1 (es) | 1965-05-16 |
| DK113945B (da) | 1969-05-12 |
| CH484276A (de) | 1970-01-15 |
| AT259133B (de) | 1967-12-27 |
| LU46667A1 (enrdf_load_stackoverflow) | 1965-02-01 |
| BE651300A (enrdf_load_stackoverflow) | 1900-01-01 |
| NL6408788A (enrdf_load_stackoverflow) | 1965-02-02 |
| SE328371B (enrdf_load_stackoverflow) | 1970-09-14 |
| BR6461321D0 (pt) | 1973-09-20 |
| IL21785A (en) | 1968-05-30 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| Rowley | The virulence of strains of Bacterium coli for mice | |
| Lancefield | Studies on the antigenic composition of group A hemolytic streptococci: I. Effects of proteolytic enzymes on streptococcal cells | |
| Dubos et al. | The effect of a tissue enzyme upon pneumococci | |
| Wentz et al. | Clostridium botulinum type F: seasonal inhibition by Bacillus licheniformis | |
| Maitland et al. | Experiments on the cultivation of vaccinia virus | |
| GB1090754A (en) | Improvements relating to immunising materials | |
| Dawson | The transformation of pneumococcal types: I. the conversion of r forms of pneumococcus into s forms of the homologous type | |
| Roberts | Toxic, allergenic and immunogenic factors of Fusiformis necrophorus | |
| Cole et al. | The production of antipneumococcic serum | |
| Weiss | Observations on Bacterium melaninogenicum: Demonstration of Fibrinolysin, Pathogenicity and Serological Types. | |
| Teale | Some Observations on the Relative Importance of the Reticulo-Endothelial Tissues and the Circulating Antibody in Immunity: I. Bacterial Immunity in Relation to the Rôle Played by the Circulating Antibody and the Tissues Following Intravenous Introduction of the Bacteria | |
| Gledhill et al. | The toxicity of some bacterial filtrates for mice pre-infected with Eperythrozöon coccoides | |
| Ospeck et al. | Pertussis antitoxin: its relationship to protection in actively and passively immunized mice and rabbits | |
| Li | STUDIES ON THE DISSOCIATION OF THE HOG CHOLERA BACILLUS: III. ACTIVE IMMUNIZATION WITH R FORMS | |
| Smith | Mycoplasma mycoides var. mycoides: immunity and mouse-protective antibody | |
| Fisher | Experimental Staphylococcal Infection of the Subcutaneous Tissue of the Mouse: II. Promotion of the Infection with Staphylococcal Cells and Products | |
| Cortiñas et al. | Alpha-Toxin Production ByClostridium Septicumat Different Culture Conditions | |
| Dulaney | Microbic dissociation of B. coli-communis | |
| USHIBA et al. | STUDIES ON THE IMMUNITY OF EXPERIMENTAL TYPHOID III. A COMPARATIVE STUDY OF ACTIVE AND PASSIVE IMMUNIZATIONS AGAINST THE INFECTION OF MICE WITH SALMONELLA ENTERITIDIS | |
| Henderson | Studies on Clostridium chauvœi. II: Active Immunization with Pure “O” Antigen | |
| Yamamoto et al. | Production of, and susceptibility to, bacteriocin-like substances in oral streptococci | |
| Dubos | The effect of the bacteriolytic enzyme of pneumococcus upon the antigenicity of encapsulated pneumococci | |
| Means et al. | Thermostability of antigens associated with serotype of Rhizobium japonicum | |
| Clark et al. | A filtrable toxic product of the hemolytic streptococcus | |
| Sato et al. | Immunogenicity of highly purified α-toxoid of Clostridium perfringens |